| 摘要 |
A method for the diagnosis of GvHD, the method comprising: c) measuring the presence or the absence of a polypeptide marker in a urine sample, wherein the polypeptide marker is selected from the group of polypeptide markers shown in table 1, and d) comparing the probability of the presence of this marker in a disease patient to the probability of the presence of this marker in a control patient, wherein c1) if the probability of the presence of this marker in a disease patient is higher than the probability of the presence of this marker in a control patient, the presence of this marker is indicative for a higher probability of having the disease rather than the control condition, or c2) if the probability of the presence of this marker in a disease patient is lower than the probability of the presence of this marker in a control patient, the absence of the marker is indicative for a higher probability of having the disease rather than the control condition.
|
